Benzinga | Feb 23, 2021 04:15PM EST

Arena Pharmaceuticals Q4 EPS $(2.10) Misses $(1.85) Estimate

Arena Pharmaceuticals (NASDAQ:ARNA) reported quarterly losses of $(2.10) per share which missed the analyst consensus estimate of $(1.85) by 13.51 percent. This is a 19.32 percent decrease over losses of $(1.76) per share from the same period last year.